Literature DB >> 7768600

High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi.

S J Norris1, J K Howell, S A Garza, M S Ferdows, A G Barbour.   

Abstract

Borrelias that cause Lyme disease lose the ability to infect and cause disease in laboratory animals following 10 to 16 passages of in vitro culture. In this study, clonal populations of the Sh-2-82 (Sh2) and B31 strains of Borrelia burgdorferi were isolated by subsurface plating on BSK-II agar plates and examined for infectivity in the C3H/HeN mouse model. Mice were injected intradermally with 10(5) B. burgdorferi organisms, and the tibiotarsal joint, heart, and bladder were cultured 2 to 4 weeks postinfection to determine whether viable organisms were present. Clones exhibited either a high-infectivity phenotype, in which cultures were consistently positive at all organ sites, or a low-infectivity phenotype, in which a low proportion of cultures were positive (5 of 40 in a representative experiment). In an Sh2 population that had undergone five in vitro passages, 7 of 10 clones were of the high-infectivity phenotype, and the remaining clones were of the low-infectivity phenotype. The proportion of high-infectivity clones decreased with continued in vitro passage, with only 1 of 10 clones exhibiting the high-infectivity phenotype after 10 passages and 0 of 10 clones yielding positive cultures after 20 passages. Representative high- and low-infectivity clones from passage 5 Sh2 cultures had 50% infectious doses of 1.8 x 10(2) and 1 x 10(5), respectively. Subclones consistently reflected the same infectivity phenotypes as those of the parent clones. The protein profiles and plasmid contents of the high- and low-infectivity clones were compared and exhibited few discernible differences. On the basis of these results, the loss of infectivity during in vitro culture results from the outgrowth of low-infectivity clones and begins to occur within the first five in vitro passages. Further examination of clonal populations may lead to the identification of genetic and protein factors important in the virulence and pathogenicity of Lyme disease borrelias.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768600      PMCID: PMC173287          DOI: 10.1128/iai.63.6.2206-2212.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  Antigenic variation and strain heterogeneity in Borrelia spp.

Authors:  B Wilske; A G Barbour; S Bergström; N Burman; B I Restrepo; P A Rosa; T Schwan; E Soutschek; R Wallich
Journal:  Res Microbiol       Date:  1992 Jul-Aug       Impact factor: 3.992

2.  High resolution two-dimensional electrophoresis of basic as well as acidic proteins.

Authors:  P Z O'Farrell; H M Goodman; P H O'Farrell
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

Review 3.  The biological and social phenomenon of Lyme disease.

Authors:  A G Barbour; D Fish
Journal:  Science       Date:  1993-06-11       Impact factor: 47.728

4.  Variation in a major surface protein of Lyme disease spirochetes.

Authors:  A G Barbour; S L Tessier; S F Hayes
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

5.  Lyme disease-a tick-borne spirochetosis?

Authors:  W Burgdorfer; A G Barbour; S F Hayes; J L Benach; E Grunwaldt; J P Davis
Journal:  Science       Date:  1982-06-18       Impact factor: 47.728

6.  Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

Authors:  G Baranton; D Postic; I Saint Girons; P Boerlin; J C Piffaretti; M Assous; P A Grimont
Journal:  Int J Syst Bacteriol       Date:  1992-07

7.  Genetic transformation of the Lyme disease agent Borrelia burgdorferi with coumarin-resistant gyrB.

Authors:  D S Samuels; K E Mach; C F Garon
Journal:  J Bacteriol       Date:  1994-10       Impact factor: 3.490

8.  Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.

Authors:  S J Norris; C J Carter; J K Howell; A G Barbour
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  Analysis of the distribution and molecular heterogeneity of the ospD gene among the Lyme disease spirochetes: evidence for lateral gene exchange.

Authors:  R T Marconi; D S Samuels; R K Landry; C F Garon
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

10.  Rapid dissemination by the agent of Lyme disease in hosts that permit fulminating infection.

Authors:  C M Shih; S R Telford; R J Pollack; A Spielman
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

View more
  70 in total

1.  Molecular and evolutionary characterization of the cp32/18 family of supercoiled plasmids in Borrelia burgdorferi 297.

Authors:  M J Caimano; X Yang; T G Popova; M L Clawson; D R Akins; M V Norgard; J D Radolf
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  A second allele of eppA in Borrelia burgdorferi strain B31 is located on the previously undetected circular plasmid cp9-2.

Authors:  J C Miller; J L Bono; K Babb; N El-Hage; S Casjens; B Stevenson
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

3.  Culturing selects for specific genotypes of Borrelia burgdorferi in an enzootic cycle in Colorado.

Authors:  D E Norris; B J Johnson; J Piesman; G O Maupin; J L Clark; W C Black
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

4.  Borrelia burgdorferi organisms lacking plasmids 25 and 28-1 are internalized by human blood phagocytes at a rate identical to that of the wild-type strain.

Authors:  Samiya Al-Robaiy; Jens Knauer; Reinhard K Straubinger
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  The BBA01 protein, a member of paralog family 48 from Borrelia burgdorferi, is potentially interchangeable with the channel-forming protein P13.

Authors:  Marija Pinne; Katrin Denker; Elin Nilsson; Roland Benz; Sven Bergström
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

6.  Borrelia burgdorferi RevA Significantly Affects Pathogenicity and Host Response in the Mouse Model of Lyme Disease.

Authors:  Rebecca Byram; Robert A Gaultney; Angela M Floden; Christopher Hellekson; Brandee L Stone; Amy Bowman; Brian Stevenson; Barbara J B Johnson; Catherine A Brissette
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

7.  Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans.

Authors:  Joshua R Fischer; Kimberly T LeBlanc; John M Leong
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

8.  Cloning and molecular characterization of plasmid-encoded antigens of Borrelia burgdorferi.

Authors:  J T Skare; D M Foley; S R Hernandez; D C Moore; D R Blanco; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 9.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

10.  Experimental assessment of the roles of linear plasmids lp25 and lp28-1 of Borrelia burgdorferi throughout the infectious cycle.

Authors:  Dorothee Grimm; Christian H Eggers; Melissa J Caimano; Kit Tilly; Philip E Stewart; Abdallah F Elias; Justin D Radolf; Patricia A Rosa
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.